BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tam RY, van Dorst JM, McKay I, Coffey M, Ooi CY. Intestinal Inflammation and Alterations in the Gut Microbiota in Cystic Fibrosis: A Review of the Current Evidence, Pathophysiology and Future Directions. J Clin Med 2022;11:649. [PMID: 35160099 DOI: 10.3390/jcm11030649] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Anderson JL, Tierney AC, Miles C, Kotsimbos T, King SJ. Probiotic knowledge of adults with cystic fibrosis is limited but is associated with probiotic use: A cross-sectional survey study. Nutr Health 2022. [DOI: 10.1177/02601060221136653] [Reference Citation Analysis]
2 Petsakou A, Perrimon N. Bioelectric regulation of intestinal stem cells. Trends in Cell Biology 2022. [DOI: 10.1016/j.tcb.2022.10.003] [Reference Citation Analysis]
3 Scull CE, Luo M, Jennings S, Taylor CM, Wang G. Cftr deletion in mouse epithelial and immune cells differentially influence the intestinal microbiota. Commun Biol 2022;5:1130. [PMID: 36289287 DOI: 10.1038/s42003-022-04101-5] [Reference Citation Analysis]
4 Wu Y, Pei C, Wang X, Wang Y, Huang D, Shi S, Shen Z, Li S, He Y, Wang Z, Wang J. Probiotics ameliorates pulmonary inflammation via modulating gut microbiota and rectifying Th17/Treg imbalance in a rat model of PM2.5 induced lung injury. Ecotoxicol Environ Saf 2022;244:114060. [PMID: 36115151 DOI: 10.1016/j.ecoenv.2022.114060] [Reference Citation Analysis]
5 Wilschanski M, Peckham D. Nutritional and metabolic management for cystic fibrosis in a post-cystic fibrosis transmembrane conductance modulator era. Current Opinion in Pulmonary Medicine 2022;Publish Ahead of Print. [DOI: 10.1097/mcp.0000000000000917] [Reference Citation Analysis]
6 Esposito S, Testa I, Mariotti Zani E, Cunico D, Torelli L, Grandinetti R, Fainardi V, Pisi G, Principi N. Probiotics Administration in Cystic Fibrosis: What Is the Evidence? Nutrients 2022;14:3160. [DOI: 10.3390/nu14153160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Alaber O, Sabe R, Baez-Socorro V, Sankararaman S, Roesch E, Sferra TJ. Epidemiology of Eosinophilic Esophagitis in Patients with Cystic Fibrosis: A Population-Based 5-Year Study. Pediatr Gastroenterol Hepatol Nutr 2022;25:283-92. [PMID: 35903489 DOI: 10.5223/pghn.2022.25.4.283] [Reference Citation Analysis]
8 Bhattacharya R, Blankenheim Z, Scott PM, Cormier RT. CFTR and Gastrointestinal Cancers: An Update. JPM 2022;12:868. [DOI: 10.3390/jpm12060868] [Reference Citation Analysis]
9 Roda J, Maia C, Almeida S, Oliveira RC, Ferreira R, Oliveira G. Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study. bmjpo 2022;6:e001422. [DOI: 10.1136/bmjpo-2022-001422] [Reference Citation Analysis]